DCGI removes Covaxin out of ‘clinical trial mode’2 min read . Updated: 11 Mar 2021, 08:15 PM IST
- Covaxin is now in ‘regular’ emergency use authorisation, and our terminology for this is that it is now allowed for restricted use in emergency situations, an official said
- The omission of the clinical trial mode followed the company’s announcement of its interim phase 3 trial data, which showed the vaccine had an 80.6% efficacy
The Drugs Controller General of India V.G. Somani has accepted a subject expert committee’s (SEC) recommendation to remove the condition of ‘clinical trial mode’ for use of Bharat Biotech International’s covid-19 vaccine Covaxin, NITI Aayog member (health) Vinod K. Paul said on Thursday.
Select your Category